Ticker League

Ovid Therapeutics (OVID) Income Statement Waterfall

Follow every dollar of Ovid Therapeutics's revenue down to net income — how much COGS, OpEx, and taxes each consume, and the margin that survives at every step.

TTM

Revenue

$7.12M

Gross Margin

+99.5%

Operating Margin

-670.2%

Net Margin

-339.3%

Income statement waterfall for Ovid Therapeutics (OVID) — TTM through Q1 2026

Net income: −$24.17M

Margin breakdown for Ovid Therapeutics (OVID) — TTM through Q1 2026

  • Revenue$7.12M
  • Cost of Revenue−$35.00K
  • Gross Profit$7.09M
  • Operating Expenses−$54.82M
  • Operating Income−$47.73M
  • Other Income / Expense$23.57M
  • Pre-tax Income−$24.17M
  • Income Tax$0.00
  • Net Loss−$24.17M
Want to see what changed vs last year?Profit Bridge

Frequently asked questions

Data & methodology

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation